The Company will provide further updates following communications with the FDA when additional information is available.

Leading herbal medicine experts from the University of the Philippines Manila have developed an anti-gout tablet derived from ...

Drug Development of XORLOTM ... however 3 to 5% of patients cannot tolerate Allopurinol. An alternative XOI, Febuxostat, was launched in the US in 2009 with the hope of treating individuals ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...

An alternative XOI, Febuxostat, was launched in the US in 2009 with the hope ... the FDA Type B meetings for each potential application (e.g., investigational new drug application (IND), NDA, ...

Current first-line therapies like allopurinol and febuxostat can be very effective ... Amgen reported sales of $272 million for the drug after it took ownership in 2023 and $235 million in ...

Here’s how it works. The best tablets in Australia provide users with a unique blend of versatility, power and portability that makes them an attractive option for various kinds of customer.

Most of the tablets included in this guide are older-generation models, so you may have to visit third-party retailers to pick them up, but where possible, we've provided links to those retailers ...

The best gaming tablets offer more than just a screen for play. These devices need to juggle productivity features and entertainment options to make their prices worthwhile, all while still ...